U.K. drug control: retrospect and prospect.
作者信息
Binns T B
出版信息
Br J Clin Pharmacol. 1981 Oct;12(4):449-51. doi: 10.1111/j.1365-2125.1981.tb01250.x.
Abstract
摘要
相似文献
1
U.K. drug control: retrospect and prospect.英国的药物管制：回顾与展望
Br J Clin Pharmacol. 1981 Oct;12(4):449-51. doi: 10.1111/j.1365-2125.1981.tb01250.x.
2
Crying wolf on drug safety.在药物安全问题上谎报险情。
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):219-20.
3
IV. Recent medicine legislation in the United Kingdom and its effect on manufacturing practice.
Bull Parenter Drug Assoc. 1974 Jul-Aug;28(4):174-80.
4
Drug regulatory agencies: a Canadian perspective.
Int J Clin Pharmacol. 1973 Jul;7(4):348-54.
5
America's drug problem.美国的毒品问题。
Hastings Cent Rep. 2012 Jul-Aug;42(4):9-10. doi: 10.1002/hast.59.
6
Drug development, regulation, and the practice of medicine.
JAMA. 1974 Sep 9;229(11):1457-61.
7
Health Canada wants more funds from pharma.加拿大卫生部希望从制药公司获得更多资金。
CMAJ. 2017 Jun 19;189(24):E845-E846. doi: 10.1503/cmaj.1095439.
8
[Is openness in the drug market possible?].[药品市场能开放吗？]
Internist (Berl). 1986 Jan;27(1):21-31.
9
Experience under the revised drug regulations.
Bull Parenter Drug Assoc. 1961 Nov-Dec;15:8-18.
10
Validation--how much can the world afford? Are we getting value for money?
J Pharm Sci Technol. 1994 Jan-Feb;48(1):45-8.
引用本文的文献
1
The role of the pharmaceutical industry in diabetes research.
Diabetologia. 1982 Sep;23(3):216-9. doi: 10.1007/BF00252844.
2
Six months experience of new procedures affecting the conduct of clinical trials in the United Kingdom.影响英国临床试验开展的新程序的六个月经验。
Br J Clin Pharmacol. 1982 Feb;13(2):253-5. doi: 10.1111/j.1365-2125.1982.tb01374.x.
本文引用的文献
1
On regulating regulation.
Eur J Clin Pharmacol. 1981 Jan;19(1):1-2. doi: 10.1007/BF00558369.
2
A survey of products licensed in the United Kingdom from 1971-1981.一项对1971年至1981年在英国获得许可的产品的调查。
Br J Clin Pharmacol. 1981 Oct;12(4):453-63. doi: 10.1111/j.1365-2125.1981.tb01251.x.
3
Drug discovery and introduction: regulation and overregulation.药物研发与引入：监管与过度监管
Clin Pharmacol Ther. 1976 Nov;20(5):507-11. doi: 10.1002/cpt1976205507.
4
The rate of development of new drugs in the United States, 1963 through 1975.1963年至1975年美国新药的研发速度。
Clin Pharmacol Ther. 1978 Aug;24(2):133-45. doi: 10.1002/cpt1978242133.
5
Constraints of drug regulation on the development of new drugs.
Arch Toxicol. 1979 Oct;43(1):9-17. doi: 10.1007/BF00695869.
Zotero 插件